Allogeneic peripheral blood stem cell transplantations in children - A single center experience

Neoplasma

Volumn 51, Issue 2, 2004, Pages 110-116

  Sufliarska S ^a   Horakova J ^a   Bodova I ^a   Martinka, J ^b   Hrubisko M ^b   Kovacs L ^a   Jancovicova K ^a   Lukac J ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Allogeneic peripheral stem cell transplantation; G CSF mobilization; Graft versus host disease; Transplant related mortality

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; DONOR; EXPERIENCE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKAPHERESIS; MALE; OPPORTUNISTIC INFECTION; RELAPSE; REMISSION; SAFETY; SIBLING;

EID: 2342519254     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. ANDERLINI P, RIZZO JD, NUGET ML, SCHMITZ N, CHAMPLIN RE, HOROWITZ MM. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant 2001; 27: 689-692.
2. ATKINSON K, HOROWITZ MM, GALE RP, LEE MB, RIMM AA, BORTIN MM. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant registry. Bone Marrow Transplant 1989; 4: 247-254.
3. BADER P, HOLLE W, KLINGEBIEL T, HANDGRETINGER R, BENDA N et al. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children. Bone Marrow Transplant 1997; 19: 697-702.
4. BENITO AL, GONZALEZ-VICENT M, GARCIA A, BALAS A, QUINTERO V et al. Allogeneic peripheral blood stem cell transplantation (PBSCT) from HLA-identical sibling donors in children with hematological diseases: a single center pilot study. Bone Marrow Transplant 2001; 28: 537-543.
5. BENSINGER W, CLIFT R, MARTIN P, APPELBAUM FR, DEMIRER T et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: Aretrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
6. BENSINGER W, MARTIN P, STORER B, CLIFT R, FORMAN S et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. New Engl J Med 2001; 344: 175-181.
7. BENSINGER W, WEAVER C H, APPELBAUM F, ROWLEY S, DEMIRER T et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony - stimulating factor. Blood 1995; 85: 1655-1658.
8. BLAISE D, KUENTZ M, FORTANIER C, BOURHIS JH, MILPIED N et al. Randomised trial of bone marrow versus lenograstim - primed blood cell allogeneic transplantation in patients with early stage leukaemia: A report from the Société Francaise de Greffe de Moelle. J Clin Oncol 2000; 18: 537-546.
9. BROWN RA, ADKINS D, KHOURY H, VIJ R, GOODNOUGH LT et al. Long-term follow-up of high-risk allogeneic peripheral blood stem cell transplant recipients: Graft-versus-host disease and transplant-related mortality. J Clin Oncol 1999; 17: 806-812.
10. CHAMPLIN RE, SCHMITZ N, HOROWITZ M, CHAPUIS B, CHOPRA R et al. Blood stem cells versus bone marrow as a source of haematopoietic cells for allogeneic transplantation. Blood 2000; 95: 3702-3709.
11. COUBAN S, SIMPSON D, BARNETT MJ, BREDESON C, HUBESCH L et al. Arandomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002; 100: 1525-1531.
12. CUTLER C, GIRI S, JEYAPALAN S, PANIAGUA D, VISWANATHAN A et al. Acute and chronic graft-versus host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685-3691.
13. DIAZ MA, ALEGRE A, VILLA M, BENITO A, BERNARDO MR et al. Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children with haematological malignancies. Br J Haematol 1997; 96: 161-164.
14. ELMAAGACLI AH, BASOGLU S, PECENY R, TRENSCHEL R, OTTINGER H et al. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia. Blood 2002; 99: 1130-1135.
15. FLOWERS M, PARKER P, JOHNSTON L, MATOS A, STORER B et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002; 100: 415-419.
16. GARDERET L, LABOPIN M, GORIN NC, POLGE E, FOUILLARD L et al. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with 6 peripheral blood stem cell graft compared to bone marrow. Bone Marrow Transplant 2003; 31: 23-39.
17. GLUCKSBERG H, STORB R, FEFER A, BUCKNER CD, NEIMAN PE et al. Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974; 18: 295-304.
18. GRATWOHL A, PASSWEG J, BALDOMERO H, HERMANS J, URBANO-ISPIZUA A. Hemotopoietic stem cell transplantation in Europe 1998. The Hematology Journal 2000; 1: 333-350.
19. GRATWOHL A. The role of the EBMT activity survey in the management of hematopoietic stem cell transplantation. European Group for Blood Marrow Transplantation. Int J Hematol 2002; 76 Suppl 1: 386-392.
20. GUSTAFSSON JERNBERG A, REMBERGER M, RINGDÉN O, WINIARSKI J. Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival. Bone Marrow Transplant 2003; 31: 175-181.
21. HELDAL D, TJONNFJORD G, BRINCH L, ALBRECHTSEN D, EGELAND T et al. A randomized study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant 2000; 25: 1129-1136.
22. KAPLAN EL, MEIER P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53:457-481.
23. KÖRBLING M, PRZEPIORKA D, HUH YO, ENGEL H, VAN BESIEN K et al. Allogeneic blood stem cell transplantation for refractory leukaemia and lymphoma; potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
24. LAWS HJ, NURNBERGER W, SCHMITZ M, ENCZMAN J, GOBEL U, DILLOO D. Increased incidence of chronic GVHD post related and unrelated allogeneic peripheral blood stem cell transplantation in childhood - a single center experience. Bone Marrow Transplant 2001; 27 Suppl 1: S176 (abstr. P493).
25. LEVINE JE, WILEY J, KLETZEL M, YANIK G, HUTCHINSON RJ et al. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Bone Marrow Transplant 2000; 25: 13-18.
26. LOCASCIULLI A, ARCESE W, LOCATELLI F, DI BONA E, BACIGALUPO A et al. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Lancet 2001; 357: 43-44.
27. MATSUBARA H, MAKIMOTO A, TAKAYAMA J, HIGA T, SAITO T et al. Possible clinical benefits of the use of peripheral stam cells over bone marrow in allogeneic transplantation setting for the treatment of childhood leukemia. Jpn J Clin Oncol 2001; 31: 30-34.
28. MIFLIN G, RUSSELL NH, HUTCHINSON RM, MORGAN G, POTTER M et al. Allogeneic peripheral blood stem cell transplantation for haematological malignancies - an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplant 1997; 19: 9-13.
29. MINIERO R, BUSCA A, PESSION A, RONDELLI R, UDERZO C et al. Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies. Haematologica 1999; 84: 657-660.
30. PETERS C, MINKOV M, GADNER H, KLINGEBIEL T, NIETHAMMER D. Proposal for standard recommendation for prophylaxis of graft-versus-host disease in children. Bone Marrow Transplant 1998; 21 Suppl 2: S57-S60.
31. PETERS C, MINKOV M, GADNER H KLINGEBIEL T, VOSSEN J et al. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplant 2000; 26: 405-411.
32. POWLES R, METHA J, KULKARNI S,TRELEAVAN J, MILLAR B et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000; 355: 1231-1237.
33. POWLES R, SINGHAL S, SIROHI B, TRELEAVAN J, KULKARNI C et al. Enhancement of the anti-tumor efficacy of allogeneic transplantation with the use of blood-derived stem cells: 5-year follow-up of a prospective study comparing marrow and blood allografts. Bone Marrow Transplant 2002; 29 Suppl 2: S227 (abstr. P806).
34. PRZEPIORKA D, ANDERLINI P, SALIBA R, CLEARY K, MEHRA R et al. Chronic graft-versus host disease after allogeneic blood stem cell transplantation. Blood 2001; 98: 1695-700.
35. PRZEPIORKA D, WEISDORF D, MARTIN P, KLINGEMANN H-G, BEATTY P et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
36. REMBERGER M, RINGDÉN O, BLAU IW, OTTINGER H, KREMENS B et al. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood 2001; 98: 1739-1745.
37. RINGDÉN O, LABAPIN M, BACIGALUPO A, ARCESE W, SCHAEFER UW et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 2002; 20: 4655-4664.
38. SHULMAN HM, SULLIVAN KM, WEIDEN PL, MCDONALD GB, STRIKER GE et al. Chronic graft-versus-host syndrome in man. A long-term clinico-pathological study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
39. SCHMITZ N, BACIGALUPO A, HASENCLEVER D, NAGLER A, GLUCKMAN E et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomized multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 995-1003.
40. SCHMITZ N, BEKSAC M, HASENCLEVER D, BACIGALUPO A, RUUTU T et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002; 100: 761-767.
41. SCHMITZ N, DREGER P, SUTTORP M, ROHWEDDER E, HAFERLACH T et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim. Blood 1995; 85: 1666-1669.
42. STOREK J, GOOLEY T, SIADAK M, BENSINGER W, MALONEY DG et al. Allogeneic peripheral blood stem cell transplantation may be associated with high-risk of chronic graft-versus-host disease. Blood 1997; 90: 4705-4709.
43. VICENT MG, MADERO L, ORTEGA JJ, MARTINEZ A, GOMEZ P et al. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia. Bone Marrow Transplant 2002; 30: 9-13.
44. VIGORITO A, AZEVEDO W, MARGUES J, AZEVEDO AM, EID KA et al. A randomized prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone marrow transplant 1998; 22: 1145-1151.
45. WATANABE T, KAJIUME T, ABET KAWANO Y, IWAI A, IWAI T et al. Allogeneic peripheral blood stem cell transplantation in children with hematological malignancies from HLA-matched siblings. Med Pediatr Oncol 2000; 34: 171-176.
46. ZECCA M, PRETE A, RONDELI R, LANINO E, BALDUZZI A et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002; 100: 1192-1200.